MAP2K7 and hepatocellular carcinoma: To further figure out the connection between ERK signaling pathway and cell metastasis in HCC, we used PD0325901, a MEK/ERK pathway specific inhibitor, to inhibit the activity of ERK/MAPK pathway in HepG2 and Bel7402 cells, respectively.